Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P02511: Variant p.Gly154Ser

Alpha-crystallin B chain
Gene: CRYAB
Feedback?
Variant information Variant position: help 154 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Glycine (G) to Serine (S) at position 154 (G154S, p.Gly154Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In CMD1II. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 154 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 175 The length of the canonical sequence.
Location on the sequence: help TSSLSSDGVLTVNGPRKQVS G PERTIPITREEKPAVTAAPK The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         TSSLSSDGVLTVNGPRKQVSGPERTIPITREEKPAVTAAPK

Mouse                         TSSLSSDGVLTVNGPRKQVSGPERTIPITREEKPAVAAAPK

Rat                           TSSLSSDGVLTVNGPRKQASGPERTIPITREEKPAVTAAPK

Pig                           TSSLSSDGVLTVNGPRRQASGPERTIPITREEKPAVTAAPK

Bovine                        TSSLSSDGVLTVNGPRKQASGPERTIPITREEKPAVTAAPK

Rabbit                        TSSLSSDGVLTVNGPRKQAPGPERTIPITREEKPAVTAAPK

Sheep                         TSSLSSDGVLTMNGPRKQASGPERTIPITREEKPAVTAAPK

Chicken                       TSSLSLDGVLTVSAPRKQSDVPERSIPITREEKPAIAGSQR

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 175 Alpha-crystallin B chain
Domain 56 – 164 sHSP
Region 146 – 175 Disordered
Modified residue 166 – 166 N6-acetyllysine
Glycosylation 170 – 170 O-linked (GlcNAc) threonine



Literature citations
alphaB-crystallin mutation in dilated cardiomyopathies: low prevalence in a consecutive series of 200 unrelated probands.
Pilotto A.; Marziliano N.; Pasotti M.; Grasso M.; Costante A.M.; Arbustini E.;
Biochem. Biophys. Res. Commun. 346:1115-1117(2006)
Cited for: VARIANT CMD1II SER-154;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.